U.S. markets closed

PCT Ltd (PCTL)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0136+0.0003 (+1.87%)
At close: 3:48PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0133
Open0.0132
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0129 - 0.0136
52 Week Range0.0120 - 0.0489
Volume1,847,434
Avg. Volume2,476,409
Market Cap10.411M
Beta (5Y Monthly)-1.44
PE Ratio (TTM)6.80
EPS (TTM)0.0020
Earnings DateApr 15, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • PCT LTD
    Analyst Report: Insulet CorporationInsulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 150,000 insulin-dependent diabetics are using it worldwide.
    Rating
    Fair Value
    Economic Moat
    2 days agoMorningstar
View more